Results 71 to 80 of about 59,437 (308)
Cryoablation in persistent atrial fibrillation – a critical appraisal [PDF]
Ablation of atrial fibrillation is an established treatment for the management of patients with paroxysmal and persistent atrial fibrillation. The complex pathophysiology of persistent atrial fibrillation has fuelled the concept of adjunctive substrate modification on top of pulmonary vein isolation.
Tzeis, S. +3 more
openaire +2 more sources
ABSTRACT Background Atrial fibrillation (AF) is a frequent comorbidity in patients with severe aortic valve stenosis undergoing transcatheter aortic valve implantation (TAVI). In addition, new‐onset AF can occur after TAVI. However, data on how AF affects outcomes in patients undergoing TAVI remain conflicting.
Kimberley I. Hemelrijk +23 more
wiley +1 more source
Aims Pulmonary vein isolation (PVI) alone in persistent atrial fibrillation (AF) is not as successful as in paroxysmal AF, and recent data indicate the key role of non-PV triggers.
Canpolat, Ugur +6 more
core +1 more source
Ablation of long-standing persistent atrial fibrillation [PDF]
Atrial fibrillation (AF) is the most commonly encountered arrhythmia in the clinical setting affecting nearly 6 million people in United States and the numbers are only expected to rise as the population continues to age. Broadly it is classified into paroxysmal, persistent and longstanding persistent AF. Electrical, structural and autonomic remodeling
Behram P, Mody +6 more
openaire +2 more sources
ABSTRACT Background The residual Gensini score (rGS) was developed to quantify the severity of coronary atheroma burden after coronary revascularisation. The predictive value of the rGS for clinical outcomes in patients with ST‐segment elevation myocardial infarction (STEMI) remains unexplored.
Batric Popovic +8 more
wiley +1 more source
ABSTRACT Background The EMPIRE I study assessed the early (30 days) safety and efficacy of a new fully repositionable delivery system (IMPERIA) for the commercially available ALLEGRA transcatheter aortic valve in patients with either severe native aortic stenosis or a degenerated surgical bioprosthesis.
José Antonio Baz +15 more
wiley +1 more source
Presenting Pattern of Atrial Fibrillation and Outcomes of Early Rhythm Control Therapy
BACKGROUND: Whether atrial fibrillation (AF) pattern or timing of AF therapy modifies the effectiveness of early rhythm control (ERC) is not known.OBJECTIVES: This study sought to compare clinical characteristics and outcomes in patients presenting with ...
Breithardt, Günter +7 more
core +1 more source
OBJECTIVES: This study investigated whether the serum matrix metalloproteinase-9 level is an independent predictor of recurrence after catheter ablation for persistent atrial fibrillation. METHODS: Fifty-eight consecutive patients with persistent atrial
Gang Wu +11 more
doaj +1 more source
Profibrotic pathways and atrial cardiomyopathy in persistent atrial fibrillation
I enjoyed reading the interesting article by Wu et al. 1, in which the authors demonstrated a significant relationship between matrix metalloproteinase (MMP)-9, a profibrotic and proinflammatory molecule, and recurrence of persistent atrial fibrillation (AF) after catheter ablation. The authors also reported that left atrial (LA) diameter and a history
openaire +4 more sources
ABSTRACT Background Transcatheter edge‐to‐edge repair (TEER) has become an established therapeutic option for patients with severe secondary mitral regurgitation (SMR). While randomized trials and registry data have reported outcomes up to 5 years, longer follow‐up data remain scarce.
Tobias Reithmayer +9 more
wiley +1 more source

